U.S. Markets closed

LipoScience says data shows lipoprotein particle control helps disease

LipoScience announced the online publication of data in the Journal of Clinical Lipidology demonstrating the economic benefits of managing to a low-density lipoprotein particle number measured by NMR as part of a cardiovascular disease risk-reduction strategy. The study is the first of several anticipated publications to establish the economic value proposition for LDL-P. This study models the economic benefits of managing to both LDL-P and low-density lipoprotein cholesterol targets, in comparison to managing LDL-C alone, to help reduce cardiovascular events and associated costs.